Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 12—December 2014
Dispatch

Novel Bluetongue Virus in Goats, Corsica, France, 2014

Figures
Tables
Article Metrics
83
citations of this article
EID Journal Metrics on Scopus
Stéphan ZientaraComments to Author , Corinne Sailleau, Cyril Viarouge, Dirck Höper, Martin Beer, Maria Jenckel, Bernd Hoffmann, Aurore Romey, Labib Bakkali-Kassimi, Aurore Fablet, Damien Vitour, and Emmanuel Bréard
Author affiliations: ANSES (French Agency for Food, Environmental and Occupational Health and Safety); Maisons-Alfort, France (S. Zientara, C. Sailleau, C. Viarouge, A. Romey, L. Bakkali-Kassimi, A. Fablet, D. Vitour, E. Bréard); Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany (D. Höper, M. Beer, M Jenckel, B. Hoffmann)

Cite This Article

Abstract

During 2000–2013, 4 genotypes of bluetongue virus (BTV) were detected in Corsica, France. At the end of 2013, a compulsory BTV-1 vaccination campaign was initiated among domestic ruminants; biological samples from goats were tested as part of a corresponding monitoring program. A BTV strain with nucleotide sequences suggestive of a novel serotype was detected.

Bluetongue is an infectious, noncontagious, arthropodborne viral disease of domestic and wild ruminants (1). Twenty-six distinct bluetongue virus (BTV) serotypes have been identified (2).

The first detection of bluetongue virus (BTV) on the island of Corsica, France, was in 2000, when sheep were found to be infected with BTV genotype 2 (BTV-2); the virus most likely originated from Sardinia (3). In 2003 and 2004, BTV-4 and BTV-16 were detected on Corsica (4). Since 2004, no other outbreaks of BTV had been reported on the island until September 2, 2013, when BTV-1 was isolated from 3 flocks of sheep in southern Corsica (5). In the following weeks, the virus spread across the island, and by March 2014, 169 outbreaks had been reported.

The Study

During September–December 2013, a total of 1,097 blood and spleen samples were collected from diseased or dead animals on Corsica; the samples were sent to the French National Reference Laboratory at Agence Nationale de Sécurité Sanitaire (Maisons-Alfort, France) to be tested for the presence of BTV. RNA was extracted from the samples and then amplified by using a real-time reverse transcription PCR (RT-qPCR). The ADIAVET BTV Real-time PCR Kit (bioMérieux, Saint Brieuc, France) was used for BTV group (i.e., Orbivirus Bluetongue virus) and serotype 1 detection. The LSI VetMAX European BTV Typing (1-2-4-6-8-9-11-16) Real-time PCR Kit (Life Technologies, Lissieu, France) was used for BTV-2, -4, -9, and -16 serotyping. A total of 531 samples from sheep, cattle, and goats had RT-qPCR results positive for BTV. All genotyped samples were positive only for BTV-1.

At the end of 2013, a compulsory vaccination program of domestic sheep, cattle, and goats was initiated by veterinary authorities in France. During the campaign, testing of ruminants with clinical signs of BTV was continued as part of a corresponding monitoring program.

During January–April 2014, we analyzed 436 samples from goats; 86 (19.7%) had positive BTV group RT-qPCR results. This method detects the BTV RNA genome segment 10. Of the 86 BTV-positive samples, 73 with a cycle threshold (Ct) value of <35 were genotyped: 57 (78.0%) of the samples were classified as BTV-1, and 10 (13.7%) were classified as non–BTV-1, -2, -4, -9, -16, and -25. By using various primers (Table) with a conventional in-house RT-PCR that amplifies a region of the BTV RNA genome segment 2, we obtained an amplicon for each of the 10 samples that were negative for BTV-1, -2, -4, -9, -16, and -25 (segment 2 encodes viral protein 2 and determines the serotype). The animals from which these samples came were in 5 herds that were sampled in January and February 2014. One of the 10 amplified products (806 bp) was sequenced directly and compared with homologous sequences available in the GenBank database; Blast 2.2.28 (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used for the comparison. Because the genome sequence was similar to that of the BTV-25 segment 2, we selected different primers, and by gene walking, we obtained the full coding sequence of the gene.

Figure

Thumbnail of Phylogenetic tree of segment 2, showing relationships between BTV-n (boldface) and other BTV strains available in GenBank (accession nos. are shown in parentheses). Scale bar represents the percentage of nucleotide substitutions. BTV, bluetongue virus.

Figure. Phylogenetic tree of segment 2, showing relationships between BTV-n (boldface) and other BTV strains available in GenBank (accession nos. are shown in parentheses). Scale bar represents the percentage of nucleotide substitutions....

BLASTN 2.2.29 (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to align sequences: the virus showed highest identity with the BTV-25 and BTV-26 serotypes circulating in Switzerland and Kuwait, respectively (6,7) (Figure). The complete segment 2 sequence of this new virus from Corsica (termed BTV-n; GenBank accession no. KM200718) shared 73% nt and 75% aa identify with BTV-25 sequences and 65% nt and 60% aa identity with BTV-26 sequences.

We developed a conventional in-house RT-PCR and an RT-qPCR that enabled specific detection of BTV-n by selection of BTV-n–specific primers and probe (Table). We could not detect BTV-n virus genome in any cattle or sheep samples tested in 2014, and we did not detect any co-infections with BTV-1 and BTV-n.

We attempted to isolate BTV-n from blood samples of the 10 BTV-n–positive goats; BTV-group Ct values for the samples ranged from 28.6 to 34.2. After many isolation attempts using embryonated chicken eggs as well as KC cells (a Culicoides sonorensis–derived cell line), Vero cells, and BHK (baby hamster kidney) cells, we isolated 1 virus strain by using BSR (a clone of BHK-21) cells. We used supernatants to conduct a BTV-n–specific RT-qPCR (primers shown in Table); the resulting Ct value of <17, indicated efficient virus replication. The virus was not neutralized by the reference antisera raised against BTV genotypes 1–24 and 26 or by an anti–BTV-25 serum (a titrated anti–BTV-25 serum is not available).

During May 2014, blood samples were collected from 56 goat bucks on a breeding farm located in the same area as the farms with the 4 previously sampled BTV-n–positive herds. Of the 56 sampled bucks, 51 were BTV-n positive by the BTV group–specific RT-qPCR (Ct value range 27.7–37.8). No buck was BTV-1 positive by the RT-qPCR, but 43 were positive by the BTV-n RT-qPCR; for the other 8 bucks, Ct values were beyond the positive range. Many of the bucks had not been vaccinated against BTV and showed no clinical signs of infection.

Conclusions

We report the detection and identification of a new BTV, BTV-n, that is circulating among goats on Corsica. BLAST analysis of the BTV-n RNA segment 2 suggests that this virus most likely belongs to the BTV serogroup. However, full-genome segment 2 sequence identity between BTV-n and its closest BTV relative, BTV-25, was low (73.0% homologous); thus, BTV-n may be a novel serotype.

Some criteria for defining serotype/nucleotype have been defined by Maan et al. (6) and Hofmann et al. (7). Comparison of the segment 2 nucleotide sequences of the 26 BTV serotypes enabled definition of 12 nucleotypes; members of the same segment 2 nucleotype are characterized by at least 66.9% identity in their segment 2 nucleotide sequences (7). Our findings show that BTV-n shares 73.0% identity with the full genome segment 2 sequence of BTV-25. According to criteria defined by Maan et al. (6), BTV-n cannot be considered a new nucleotype and seems to belong to the BTV-25 nucleotype. Maan et al. (8) also showed that the differences in segment 2 sequences correspond to differences in serotypes. They reported overall interserotype variations in segment 2 of 29.0% (BTV-8 and BTV-18) to 59.0% (BTV-16 and BTV-22); the deduced amino acid sequence of VP2 varied from 22.4% (BTV-4 and BTV-20) to 73.0% (BTV-6 and BTV-22) (8). However, unlike BTV-25, BTV-n can grow in BSR cells (7,9).

Like BTV-25 (9) and BTV-26 strains, BTV-n has been detected in goats without clinical signs and symptoms of infection. All of the samples positive for BTV-n by RT-qPCR were from healthy bucks, and most BTV samples from clinically affected goats were negative for BTV group by RT-qPCR. Thus, it is also likely that BTV-n is not pathogenic for goats.

We suggest, on the basis of the following findings, that the newly detected BTV-n strain could be a new serotype: the differences between BTV-n sequences and other BTV sequences were as high as those described by Maan et al. (8); BTV-n is genetically diverse from other BTVs; BTV-n could not be amplified by the BTV-25–specific RT-PCR; anti–BTV-25 serum could not neutralize BTV-n; and, unlike BTV-25, BTV-n can be cultivated on BSR cells (7,10). No information is available about the origin of this new BTV strain; more in-depth investigation is needed to determine when and how the virus arrived in Corsica. Additional genome sequencing and experiments in various ruminant species are planned. These studies will help characterize this new BTV strain and evaluate the duration of viremia, humoral immune response, and pathogenicity of this serotype.

Dr Zientara is a research scientist at the Animal Health Laboratory, Agence Nationale de Sécurité Sanitaire. His research focuses on viral emerging diseases in Europe, such as orbiviruses and orthobunyaviruses.

Top

Acknowledgments

We thank veterinarians in Corsica and the French veterinary services and departmental laboratories in Bastia and Ajaccio, Corsica, for sending samples and the diagnostic department of the Institute of Virology and Immunology, Mittelhausern, Switzerland, for the BTV-25 antiserum.

This work was supported by Agence Nationale de Sécurité Sanitaire, Friedrich Loeffler Institute and the EMIDA ERA-Net Project “OrbiNet” (BMBF FKZ031 5858).

Top

References

  1. Verwoerd  D, Erasmus  BJ. Bluetongue. In : Coetzer JAW, Tustin RC, editors. Infectious diseases of livestock. 2nd ed. Cape Town (South Africa): Oxford University Press; 2004. p. 1201–20.
  2. Maan  S, Maan  NS, Nomikou  K, Veronesi  E, Bachanek-Bankowska  K, Belaganahalli  MN, Complete genome characterisation of a novel 26th bluetongue virus serotype from Kuwait. PLoS ONE. 2011;6:e26147. DOIPubMed
  3. Zientara  S, Sailleau  C, Dauphin  G, Roquier  C, Rémond  EM, Lebreton  F, Identification of bluetongue virus serotype 2 (Corsican strain) by reverse-transcriptase PCR reaction analysis of segment 2 of the genome. Vet Rec. 2002;150:598601. DOIPubMed
  4. Zientara  S, MacLachlan  NJ, Calistri  P, Sanchez-Vizcaino  JM, Savini  G. Bluetongue vaccination in Europe. Expert Rev Vaccines. 2010;9:98991. DOIPubMed
  5. Sailleau  C,, Viarouge  C, Bréard  E, Perrin  JB, Doceul  V, Vitour  D, Zientara  S. Emergence of bluetongue virus serotype 1 in French Corsica Island in September 2013 [cited 2014 Jul 18]. Transboundary and Emerging Dis. Epub ahead of print 2014Jan 24.
  6. Maan  S, Maan  NS, Nomikou  K, Batten  C, Antony  F, Belaganahalli  MN, Novel bluetongue virus serotype from Kuwait. Emerg Infect Dis. 2011;17:8869. DOIPubMed
  7. Hofmann  MA, Renzullo  S, Mader  M, Chaignat  V, Worwa  G, Thuer  B. Genetic characterization of Toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg Infect Dis. 2008;14:185561. DOIPubMed
  8. Maan  S, Maan  NS, Samuel  AR, Rao  S, Attoui  H, Mertens  PP. Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes. J Gen Virol. 2007;88:62130. DOIPubMed
  9. Hofmann  MA, Renzullo  S, Planzer  J, Mader  M, Chaignat  V, Thuer  B. Detection of Toggenburg orbivirus by a segment 2–specific quantitative RT-PCR. J Virol Methods. 2010;165:3259. DOIPubMed
  10. Planzer  J, Kaufmann  C, Worwa  G, Gavier-Widen  D, Hofmann  MA, Chaignat  V, In vivo and in vitro propagation and transmission of Toggenburg orbivirus. Res Vet Sci. 2011;91:e1638. DOIPubMed

Top

Figure
Table

Top

Cite This Article

DOI: 10.3201/eid2012.140924

Table of Contents – Volume 20, Number 12—December 2014

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Stéphan Zientara, UPE, ANSES Maisons-Alfort–UMR ANSES/INRA/ENVA, 23 Ave du Génral de Gaulle, Maisons-Alfort 94703, France

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: November 19, 2014
Page updated: November 19, 2014
Page reviewed: November 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external